Gossamer Bio Inc (NASDAQ:GOSS) price closed lower on Tuesday, March 26, dropping -6.11% below its previous close.
A look at the daily price movement shows that the last close reads $1.31. The company’s 5Y monthly beta was ticking 1.72. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.88 and 52-week low of $0.45. The stock subtracted -3.15% on its value in the past month.
Gossamer Bio Inc, which has a market valuation of $277.46 million, is expected to release its quarterly earnings report May 07, 2024 – May 13, 2024. Analysts tracking GOSS have forecast the quarterly EPS to shrink by -0.18 per share this quarter, while the same analysts predict the annual EPS to hit -$0.74 for the year 2024 and up to -$0.69 for 2025. In this case, analysts estimate an annual EPS growth of 37.30% for the year and 6.80% for the next year.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give GOSS a short term outlook of 50% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that GOSS’s price is at present -11.16% off the SMA20 and 9.89% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 45.13, with weekly volatility standing at 5.54%. The indicator jumps to 8.94% when calculated based on the past 30 days. Gossamer Bio Inc (NASDAQ:GOSS)’s beta value is holding at 1.72, while the average true range (ATR) indicator is currently reading 0.11.
An analysis of the Gossamer Bio Inc (NASDAQ:GOSS) stock in terms of its daily trading volume indicates that the 3-month average is 1.08 million. However, this figure increases on the past 10-day timeline to an average of 1.2 million.
Current records show that the company has 225.41M in outstanding shares. The insiders’ percentage holdings are 16.30% of outstanding shares while the percentage share held by institutions stands at 79.44%. The stats also highlight that short interest as of Feb 29, 2024, stood at 14.3 million shares, which puts the short ratio at the time at 11.54. From this we can glean that short interest is 6.34% of company’s current outstanding shares. Notably, we see that shares short in February fall slightly given the previous month’s figure stood at 16.72 million. But the 34.79% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
